Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01499
|
|||||
| Drug Name |
Azasetron
|
|||||
| Synonyms |
Azasetron; Nazasetron; Azasetron [INN]; C17H20ClN3O3; 123039-99-6; WUKZPHOXUVCQOR-UHFFFAOYSA-N; Azasetron (INN); 6-Chloro-4-methyl-3-oxo-N-(quinuclidin-3-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine-8-carboxamide; NCGC00024563-02; DSSTox_RID_81029; DSSTox_CID_25651; DSSTox_GSID_45651; (- )-6-Chloro-3,4-dihydro-4-methyl-3-oxo-N-3-quinuclidinyl-2H-1,4-benzoxazine-8-carboxamide; N-(1-azabicyclo[2.2.2]octan-3-yl)-6-chloro-4-methyl-3-oxo-1,4-benzoxazine-8-carboxamide
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Nausea and vomiting [ICD11: MD90] | Approved | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C17H20ClN3O3
|
|||||
| Canonical SMILES |
CN1C(=O)COC2=C(C=C(C=C21)Cl)C(=O)NC3CN4CCC3CC4
|
|||||
| InChI |
InChI=1S/C17H20ClN3O3/c1-20-14-7-11(18)6-12(16(14)24-9-15(20)22)17(23)19-13-8-21-4-2-10(13)3-5-21/h6-7,10,13H,2-5,8-9H2,1H3,(H,19,23)
|
|||||
| InChIKey |
WUKZPHOXUVCQOR-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 123039-99-6
|
|||||
| Pharmaceutical Properties | Molecular Weight | 349.8 | Topological Polar Surface Area | 61.9 | ||
| Heavy Atom Count | 24 | Rotatable Bond Count | 2 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
1.6
|
|||||
| PubChem CID | ||||||
| PubChem SID |
4503337
, 8151522
, 14900802
, 26751695
, 29221437
, 47437793
, 48407470
, 49830627
, 50064274
, 50064275
, 51091806
, 57321227
, 77940238
, 85787806
, 103848318
, 104300087
, 117466756
, 119525144
, 124886910
, 124886911
, 126669656
, 129635800
, 135157445
, 135649974
, 136933682
, 137249308
, 137267099
, 142183976
, 144204457
, 152103821
, 160824111
, 162180413
, 163092086
, 170466158
, 179149724
, 179565728
, 184545075
, 184557777
, 204383376
, 223656708
, 226407307
, 238185794
, 249979213
, 252358890
|
|||||
| ChEBI ID |
CHEBI:91712
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | National Center for Advancing Translational Science-Inxight: drug (77HC7URR9Z) | |||||
| 2 | Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm Res. 2013 Apr;30(4):996-1007. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.